Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph M McCune

Showing results (101-110 of 162) with videos related to

Pageof 17
Sort By:
The Journal of Infectious Diseases|January 4, 2008
Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapyPeter W Hunt, Jason Brenchley, Elizabeth Sinclair, et al.
The Journal of Infectious Diseases|October 24, 2012
Cell-based measures of viral persistence are associated with immune activation and programmed cell death protein 1 (PD-1)-expressing CD4+ T cellsHiroyu Hatano, Vivek Jain, Peter W Hunt, et al.
Plos One|February 10, 2011
A low T regulatory cell response may contribute to both viral control and generalized immune activation in HIV controllersPeter W Hunt, Alan L Landay, Elizabeth Sinclair, et al.
FEBS Letters|September 12, 2017
Metabolically active CD4+ T cells expressing Glut1 and OX40 preferentially harbor HIV during in vitro infectionClovis S Palmer, Gabriel A Duette, Marc C E Wagner, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 20, 2008
Apolipoprotein (apo) E4 enhances HIV-1 cell entry in vitro, and the APOE epsilon4/epsilon4 genotype accelerates HIV disease progressionTrevor D Burt, Brian K Agan, Vincent C Marconi, et al.
The Journal of Infectious Diseases|July 16, 2013
Antiretroviral therapy initiated within 6 months of HIV infection is associated with lower T-cell activation and smaller HIV reservoir sizeVivek Jain, Wendy Hartogensis, Peter Bacchetti, et al.
AIDS (London, England)|May 30, 2014
Programmed death-1 expression on CD4⁺ and CD8⁺ T cells in treated and untreated HIV diseaseLeslie R Cockerham, Vivek Jain, Elizabeth Sinclair, et al.
AIDS (London, England)|February 9, 2016
Immunologic profiles distinguish aviremic HIV-infected adultsChristina M Ramirez, Elizabeth Sinclair, Lorrie Epling, et al.
Pathogens & Immunity|March 8, 2024
Progress Note 2024: Curing HIV; Not in My Lifetime or Just Around the Corner?Justin Harper, Michael R Betts, Mathias Lichterfeld, et al.
The Journal of Infectious Diseases|September 9, 2006
Prevalence of CXCR4 tropism among antiretroviral-treated HIV-1-infected patients with detectable viremiaPeter W Hunt, P Richard Harrigan, Wei Huang, et al.
Pageof 17

Showing results (101-110 of 162) with videos related to

Sort By:
Pageof 17
The Journal of Infectious Diseases|January 4, 2008
Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapyPeter W Hunt, Jason Brenchley, Elizabeth Sinclair, et al.
The Journal of Infectious Diseases|October 24, 2012
Cell-based measures of viral persistence are associated with immune activation and programmed cell death protein 1 (PD-1)-expressing CD4+ T cellsHiroyu Hatano, Vivek Jain, Peter W Hunt, et al.
Plos One|February 10, 2011
A low T regulatory cell response may contribute to both viral control and generalized immune activation in HIV controllersPeter W Hunt, Alan L Landay, Elizabeth Sinclair, et al.
FEBS Letters|September 12, 2017
Metabolically active CD4+ T cells expressing Glut1 and OX40 preferentially harbor HIV during in vitro infectionClovis S Palmer, Gabriel A Duette, Marc C E Wagner, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 20, 2008
Apolipoprotein (apo) E4 enhances HIV-1 cell entry in vitro, and the APOE epsilon4/epsilon4 genotype accelerates HIV disease progressionTrevor D Burt, Brian K Agan, Vincent C Marconi, et al.
The Journal of Infectious Diseases|July 16, 2013
Antiretroviral therapy initiated within 6 months of HIV infection is associated with lower T-cell activation and smaller HIV reservoir sizeVivek Jain, Wendy Hartogensis, Peter Bacchetti, et al.
AIDS (London, England)|May 30, 2014
Programmed death-1 expression on CD4⁺ and CD8⁺ T cells in treated and untreated HIV diseaseLeslie R Cockerham, Vivek Jain, Elizabeth Sinclair, et al.
AIDS (London, England)|February 9, 2016
Immunologic profiles distinguish aviremic HIV-infected adultsChristina M Ramirez, Elizabeth Sinclair, Lorrie Epling, et al.
Pathogens & Immunity|March 8, 2024
Progress Note 2024: Curing HIV; Not in My Lifetime or Just Around the Corner?Justin Harper, Michael R Betts, Mathias Lichterfeld, et al.
The Journal of Infectious Diseases|September 9, 2006
Prevalence of CXCR4 tropism among antiretroviral-treated HIV-1-infected patients with detectable viremiaPeter W Hunt, P Richard Harrigan, Wei Huang, et al.
Pageof 17